Diabetes 63 (4), 12241233
Similarly, an association was observed between GLP-1 RAs use and a lower risk of MAKEs, although it was less pronounced in patients with proteinuria and those receiving short-acting GLP-1 RAs
So I think youre looking at 5 to 10 years of innovation, all kind of expanding off of the initial GLP-1 learning and that first medication out there with liraglutide now coming off time
Importantly, the review also notes that individual responses to incretin-based therapies can vary substantially, and weight regain commonly occurs if treatment is discontinued, highlighting the chronic nature of obesity management
All information is drawn from CareBareRX's official website and published terms and conditions
Studies show that monounsaturated fats, like those in olive oil, are better at stimulating GLP-1 levels than saturated fats like butter